Press releases
- Senseonics Holdings, Inc. to Participate in Upcoming Conferences
- Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
- Eversense® CGM System Receives iCGM Designation by the US FDA
- Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
- Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
- Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
- Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time
- Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
- PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
More ▼
Key statistics
On Thursday, Senseonics Holdings Inc (6L6:DEU) closed at 0.474, 41.92% above the 52 week low of 0.334 set on Apr 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4239 |
---|---|
High | 0.474 |
Low | 0.392 |
Bid | 0.4698 |
Offer | 0.4904 |
Previous close | 0.452 |
Average volume | 1.77k |
---|---|
Shares outstanding | 530.82m |
Free float | 503.78m |
P/E (TTM) | -- |
Market cap | 275.02m USD |
EPS (TTM) | -0.1023 USD |
Data delayed at least 15 minutes, as of May 02 2024.
More ▼